Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Brd4 regulates the expression of essential autophagy genes and Keap1 in AML cells.

Huang M, Zhu L, Garcia JS, Li MX, Gentles AJ, Mitchell BS.

Oncotarget. 2018 Feb 7;9(14):11665-11676. doi: 10.18632/oncotarget.24432. eCollection 2018 Feb 20.

2.

Curbing Our Enthusiasm: An Analysis of the Check-In/Check-Out Literature Using the Council for Exceptional Children's Evidence-Based Practice Standards.

Mitchell BS, Adamson R, McKenna JW.

Behav Modif. 2017 May;41(3):343-367. doi: 10.1177/0145445516675273. Epub 2016 Nov 11. Review.

PMID:
27837154
3.

Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cells.

Huang M, Garcia JS, Thomas D, Zhu L, Nguyen LX, Chan SM, Majeti R, Medeiros BC, Mitchell BS.

Oncotarget. 2016 Nov 15;7(46):74917-74930. doi: 10.18632/oncotarget.12493.

4.

Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells.

Nguyen le XT, Zhu L, Lee Y, Ta L, Mitchell BS.

Clin Cancer Res. 2016 Jul 1;22(13):3320-7. doi: 10.1158/1078-0432.CCR-15-2282. Epub 2016 Jan 26.

5.

Selective Toxicity of Investigational Ixazomib for Human Leukemia Cells Expressing Mutant Cytoplasmic NPM1: Role of Reactive Oxygen Species.

Garcia JS, Huang M, Medeiros BC, Mitchell BS.

Clin Cancer Res. 2016 Apr 15;22(8):1978-88. doi: 10.1158/1078-0432.CCR-15-1440. Epub 2015 Dec 3.

6.

The effect of an intense mentoring program on junior investigators' preparation for a patient-oriented clinical research career.

Burns LJ, Clayton CP, George JN, Mitchell BS, Gitlin SD.

Acad Med. 2015 Aug;90(8):1061-6. doi: 10.1097/ACM.0000000000000742.

PMID:
26222198
7.

Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.

Raval A, Behbehani GK, Nguyen le XT, Thomas D, Kusler B, Garbuzov A, Ramunas J, Holbrook C, Park CY, Blau H, Nolan GP, Artandi SE, Mitchell BS.

PLoS One. 2015 Jul 2;10(7):e0131722. doi: 10.1371/journal.pone.0131722. eCollection 2015.

8.

Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1.

Nguyen le XT, Lee Y, Urbani L, Utz PJ, Hamburger AW, Sunwoo JB, Mitchell BS.

Blood. 2015 Apr 16;125(16):2519-29. doi: 10.1182/blood-2014-12-616433. Epub 2015 Feb 17.

9.

Functionalized silicon nanoparticles from reactive cavitation erosion of silicon wafers.

Wang H, Xu Z, Fink MJ, Shchukin D, Mitchell BS.

Chem Commun (Camb). 2015 Jan 28;51(8):1465-8. doi: 10.1039/c4cc06991a.

PMID:
25494039
10.

Regulation of ribosomal gene expression in cancer.

Nguyen le XT, Raval A, Garcia JS, Mitchell BS.

J Cell Physiol. 2015 Jun;230(6):1181-8. doi: 10.1002/jcp.24854. Review.

PMID:
25336383
11.

Mild two-step method to construct DNA-conjugated silicon nanoparticles: scaffolds for the detection of microRNA-21.

Su X, Kuang L, Battle C, Shaner T, Mitchell BS, Fink MJ, Jayawickramarajah J.

Bioconjug Chem. 2014 Oct 15;25(10):1739-43. doi: 10.1021/bc5004026. Epub 2014 Sep 26.

12.

Effect of CAL-101, a PI3Kδ inhibitor, on ribosomal rna synthesis and cell proliferation in acute myeloid leukemia cells.

Nguyen LX, Sesay A, Mitchell BS.

Blood Cancer J. 2014 Jul 11;4:e228. doi: 10.1038/bcj.2014.49. No abstract available.

13.

Determination of boiling point of petrochemicals by gas chromatography-mass spectrometry and multivariate regression analysis of structural activity relationship.

Fakayode SO, Mitchell BS, Pollard DA.

Talanta. 2014 Aug;126:151-6. doi: 10.1016/j.talanta.2014.03.037. Epub 2014 Mar 25.

PMID:
24881546
14.

Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cells.

Nguyen le XT, Chan SM, Ngo TD, Raval A, Kim KK, Majeti R, Mitchell BS.

Blood. 2014 Jul 24;124(4):579-89. doi: 10.1182/blood-2013-12-544726. Epub 2014 May 21.

15.

Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA.

Nguyen le XT, Mitchell BS.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20681-6. doi: 10.1073/pnas.1313097110. Epub 2013 Dec 2.

16.

Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib.

Huang M, Thomas D, Li MX, Feng W, Chan SM, Majeti R, Mitchell BS.

Leukemia. 2013 Oct;27(10):1970-80. doi: 10.1038/leu.2013.222. Epub 2013 Jul 23.

PMID:
23877794
17.

Cytotoxicity of surface-functionalized silicon and germanium nanoparticles: the dominant role of surface charges.

Bhattacharjee S, Rietjens IM, Singh MP, Atkins TM, Purkait TK, Xu Z, Regli S, Shukaliak A, Clark RJ, Mitchell BS, Alink GM, Marcelis AT, Fink MJ, Veinot JG, Kauzlarich SM, Zuilhof H.

Nanoscale. 2013 Jun 7;5(11):4870-83. doi: 10.1039/c3nr34266b. Epub 2013 Apr 25.

18.

Age and genetics: how do prognostic factors at diagnosis explain disparities in acute myeloid leukemia?

Patel MI, Ma Y, Mitchell BS, Rhoads KF.

Am J Clin Oncol. 2015 Apr;38(2):159-64. doi: 10.1097/COC.0b013e31828d7536.

PMID:
23608826
19.

Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia.

Pollyea DA, Zehnder J, Coutre S, Gotlib JR, Gallegos L, Abdel-Wahab O, Greenberg P, Zhang B, Liedtke M, Berube C, Levine R, Mitchell BS, Medeiros BC.

Haematologica. 2013 Apr;98(4):591-6. doi: 10.3324/haematol.2012.076414. Epub 2012 Dec 14.

20.

Reduced rRNA expression and increased rDNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes.

Raval A, Sridhar KJ, Patel S, Turnbull BB, Greenberg PL, Mitchell BS.

Blood. 2012 Dec 6;120(24):4812-8. doi: 10.1182/blood-2012-04-423111. Epub 2012 Oct 15.

21.

Understanding disparities in leukemia: a national study.

Patel MI, Ma Y, Mitchell BS, Rhoads KF.

Cancer Causes Control. 2012 Nov;23(11):1831-7. doi: 10.1007/s10552-012-0062-3. Epub 2012 Sep 13.

PMID:
22971999
22.

Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia.

Pollyea DA, Kohrt HE, Gallegos L, Figueroa ME, Abdel-Wahab O, Zhang B, Bhattacharya S, Zehnder J, Liedtke M, Gotlib JR, Coutre S, Berube C, Melnick A, Levine R, Mitchell BS, Medeiros BC.

Leukemia. 2012 May;26(5):893-901. doi: 10.1038/leu.2011.294. Epub 2011 Oct 28.

PMID:
22033493
23.

Effect of nucleophosmin1 haploinsufficiency on hematopoietic stem cells.

Raval A, Kusler B, Pang WW, Weissman IL, Mitchell BS, Park CY.

Leukemia. 2012 Apr;26(4):853-5. doi: 10.1038/leu.2011.270. Epub 2011 Oct 7. No abstract available.

24.

Successful intraoperative retrieval of dislocated femoral trial head during total hip arthroplasty.

Madsen WY, Mitchell BS, Kates SL.

J Arthroplasty. 2012 May;27(5):820.e9-11. doi: 10.1016/j.arth.2011.08.006. Epub 2011 Oct 2.

PMID:
21964233
25.

Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitors.

Pollyea DA, Raval A, Kusler B, Gotlib JR, Alizadeh AA, Mitchell BS.

Hematol Oncol. 2011 Sep;29(3):157-60. doi: 10.1002/hon.976. Epub 2010 Oct 27. No abstract available.

PMID:
21922510
26.

Morphometry of the synovial folds of the lateral atlanto-axial joints: the anatomical basis for understanding their potential role in neck pain.

Webb AL, Rassoulian H, Mitchell BS.

Surg Radiol Anat. 2012 Mar;34(2):115-24. doi: 10.1007/s00276-011-0834-6. Epub 2011 Jun 12.

PMID:
21667263
27.

Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.

Huang M, Whang P, Lewicki P, Mitchell BS.

Mol Pharmacol. 2011 Jul;80(1):40-8. doi: 10.1124/mol.110.070284. Epub 2011 Apr 4.

28.

Reactive oxygen species regulate nucleostemin oligomerization and protein degradation.

Huang M, Whang P, Chodaparambil JV, Pollyea DA, Kusler B, Xu L, Felsher DW, Mitchell BS.

J Biol Chem. 2011 Apr 1;286(13):11035-46. doi: 10.1074/jbc.M110.208470. Epub 2011 Jan 17.

29.

Synovial folds - a pain in the neck?

Webb AL, Collins P, Rassoulian H, Mitchell BS.

Man Ther. 2011 Apr;16(2):118-24. doi: 10.1016/j.math.2010.11.004. Epub 2011 Jan 8. Review.

PMID:
21216653
30.

Synthesis of 2'-deoxy-2'-[18F]fluoro-9-β-D-arabinofuranosylguanine: a novel agent for imaging T-cell activation with PET.

Namavari M, Chang YF, Kusler B, Yaghoubi S, Mitchell BS, Gambhir SS.

Mol Imaging Biol. 2011 Oct;13(5):812-8. doi: 10.1007/s11307-010-0414-x.

PMID:
20838911
31.

Wetting properties of silicon films from alkyl-passivated particles produced by mechanochemical synthesis.

Hallmann S, Fink MJ, Mitchell BS.

J Colloid Interface Sci. 2010 Aug 15;348(2):634-41. doi: 10.1016/j.jcis.2010.05.003. Epub 2010 May 6.

PMID:
20580764
32.

A cross-cultural comparison of anatomy learning: learning styles and strategies.

Mitchell BS, Xu Q, Jin L, Patten D, Gouldsborough I.

Anat Sci Educ. 2009 Mar-Apr;2(2):49-60. doi: 10.1002/ase.73.

PMID:
19347948
33.

Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin.

Huang M, Itahana K, Zhang Y, Mitchell BS.

Cancer Res. 2009 Apr 1;69(7):3004-12. doi: 10.1158/0008-5472.CAN-08-3413. Epub 2009 Mar 24.

34.

Guanine nucleotide depletion mediates translocation of nucleolar proteins, including RNA helicase A (DHX-9).

Huang M, Mitchell BS.

Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):704-11. doi: 10.1080/15257770802145132.

PMID:
18600529
35.

Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H.

Huang M, Wang Y, Gu J, Yang J, Noel K, Mitchell BS, Schramm VL, Graves LM.

Leuk Res. 2008 Aug;32(8):1268-78. doi: 10.1016/j.leukres.2007.12.015. Epub 2008 Feb 14.

36.

Tenascin C interacts with ecto-5'-nucleotidase (eN) and regulates adenosine generation in cancer cells.

Sadej R, Inai K, Rajfur Z, Ostapkowicz A, Kohler J, Skladanowski AC, Mitchell BS, Spychala J.

Biochim Biophys Acta. 2008 Jan;1782(1):35-40. Epub 2007 Nov 13.

37.

Looking 'back to the future': alumni perceptions of a UK undergraduate medical programme.

Lueddeke GR, Anderson FH, Carr NJ, Mitchell BS, Taylor ME.

Med Teach. 2006 Nov;28(7):654-6.

PMID:
17594560
38.

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.

DeAngelo DJ, Yu D, Johnson JL, Coutre SE, Stone RM, Stopeck AT, Gockerman JP, Mitchell BS, Appelbaum FR, Larson RA.

Blood. 2007 Jun 15;109(12):5136-42. Epub 2007 Mar 7.

39.

Relationship between bone ingrowth, mineral apposition rate, and osteoblast activity.

Bloebaum RD, Willie BM, Mitchell BS, Hofmann AA.

J Biomed Mater Res A. 2007 May;81(2):505-14. Review.

PMID:
17236212
40.

Effect of lysophosphatidic acid acyltransferase-beta inhibition in acute leukemia.

Douvas MG, Hogan KN, Ji Y, Hollenback D, Bonham L, Singer JW, Mitchell BS.

Leuk Res. 2006 Aug;30(8):1027-36. Epub 2006 Feb 20.

PMID:
16488473
41.

Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic Acid by GTP.

Ji Y, Gu J, Makhov AM, Griffith JD, Mitchell BS.

J Biol Chem. 2006 Jan 6;281(1):206-12. Epub 2005 Oct 21.

42.

The 5'-nucleotidases as regulators of nucleotide and drug metabolism.

Hunsucker SA, Mitchell BS, Spychala J.

Pharmacol Ther. 2005 Jul;107(1):1-30. Review.

PMID:
15963349
43.

Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies.

Kurtzberg J, Ernst TJ, Keating MJ, Gandhi V, Hodge JP, Kisor DF, Lager JJ, Stephens C, Levin J, Krenitsky T, Elion G, Mitchell BS.

J Clin Oncol. 2005 May 20;23(15):3396-403.

PMID:
15908652
44.

ACCO: ASCO core curriculum outline.

Muss HB, Von Roenn J, Damon LE, Deangelis LM, Flaherty LE, Harari PM, Kelly K, Kosty MP, Loscalzo MJ, Mennel R, Mitchell BS, Mortimer JE, Muggia F, Perez EA, Pisters PW, Saltz L, Schapira L, Sparano J; American Society of Clinical Oncology.

J Clin Oncol. 2005 Mar 20;23(9):2049-77. Epub 2005 Feb 22. No abstract available.

PMID:
15728218
45.

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies.

Orlowski RZ, Voorhees PM, Garcia RA, Hall MD, Kudrik FJ, Allred T, Johri AR, Jones PE, Ivanova A, Van Deventer HW, Gabriel DA, Shea TC, Mitchell BS, Adams J, Esseltine DL, Trehu EG, Green M, Lehman MJ, Natoli S, Collins JM, Lindley CM, Dees EC.

Blood. 2005 Apr 15;105(8):3058-65. Epub 2004 Dec 30.

46.

Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl.

Gu JJ, Santiago L, Mitchell BS.

Blood. 2005 Apr 15;105(8):3270-7. Epub 2004 Dec 16.

47.

Regulation of equilibrative nucleoside uptake by protein kinase inhibitors.

Huang M, Wang Y, Mitchell BS, Graves LM.

Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1445-50. Review.

PMID:
15571274
48.

Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part I. In vivo studies.

Malek K, Boosalis MS, Waraska K, Mitchell BS, Wright DG.

Leuk Res. 2004 Nov;28(11):1125-36.

PMID:
15380335
49.

Teaching anatomy as a multimedia experience.

Mitchell BS, Stephens CR.

Med Educ. 2004 Aug;38(8):911-2; author reply 912-3. No abstract available.

PMID:
15271054
50.

Student attitudes towards anatomy teaching and learning in a multiprofessional context.

Mitchell BS, McCrorie P, Sedgwick P.

Med Educ. 2004 Jul;38(7):737-48.

PMID:
15200398

Supplemental Content

Loading ...
Support Center